| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |